PDL BioPharma Inc. (PDLI)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 0 |
Ownership rank: | -- |
% of all portfolios: | 0% |
History | Portfolio Manager | Activity | Share change | % change to portfolio ▲ | |
Q3  2011 | |||||
≡ | Seth Klarman - Baupost Group | Add 68.81% | 6,373,675 | 1.19 | |
Q1  2011 | |||||
≡ | Seth Klarman - Baupost Group | Add 87.30% | 4,891,825 | 1.66 | |
Q4  2010 | |||||
≡ | Seth Klarman - Baupost Group | Buy | 5,603,400 | 2.08 | |
Q1  2009 | |||||
≡ | Seth Klarman - Baupost Group | Add 8.33% | 1,195,859 | 0.84 | |
Q4  2008 | |||||
≡ | Seth Klarman - Baupost Group | Add 3.63% | 503,289 | 0.28 | |
Q2  2008 | |||||
≡ | Seth Klarman - Baupost Group | Add 3111.66% | 14,363,400 | 7.70 | |
Q1  2008 | |||||
≡ | Seth Klarman - Baupost Group | Buy | 461,600 | 0.30 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.